Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registrySalomon M. Stemmer, Nicky Liebermann, Noa Ben-Baruch et al.|npj Breast Cancer|2017Cited by 70
Treatments/clinical outcomes in ER+ HER2-negative breast cancer (BC) where treatment decisions were recurrence score (RS)-guided: Analysis by histologic subtype.Salomon M. Stemmer, Nicky Liebermann, Mariana Steiner et al.|Journal of Clinical Oncology|2017Cited by 0